SUTRO BIOPHARMA, INC. Total Shareholder Rtn Amt
SUTRO BIOPHARMA, INC. (STRO) reported Total Shareholder Rtn Amt of $14 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-22.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-04-22
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $14.00 DEF 14A · filed 2026-04-22 |
| 2024-12-31 | $23.00 DEF 14A · filed 2026-04-22 |
| 2023-12-31 | $53.00 DEF 14A · filed 2026-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |